Dynavax (DVAX) Tops Q4 EPS by 1c
Tweet
Share
E-mail
Get Alerts DVAX Hot Sheet
Price: $15.50 --0%
Financial Fact:
Basic and diluted net loss per share: -0.9
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
Basic and diluted net loss per share: -0.9
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Dynavax (NASDAQ: DVAX) reported Q4 EPS of $0.05, $0.01 better than the analyst estimate of $0.04. Revenue for the quarter came in at $71.1 million versus the consensus estimate of $72.44 million.
GUIDANCE:
Dynavax sees FY2025 revenue of $305-325 million, versus the consensus of $332.4 million.
For earnings history and earnings-related data on Dynavax (DVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- TrustBix extends private placement deadline to October 22
- Decoy Therapeutics corrects warrant exercisability in inducement deal
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
